Clinical trials: Pancreatic Resection
- Condition Pancreatic Resection
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Resected Pancreatic Cancer, Pancreatic Cancer
A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan
To verify the efficacy of S-1 adjuvant chemotherapy in resectable pancreatic cancer. Primary Endpoint: Relapse-free survival (RFS) Secondary Endpoints: 2-year survival rate, 2-year relapse-free survival (RFS) rate, safety profile
- Conditions
- Resected Pancreatic Cancer, Pancreatic Cancer, Adjuvant Chemotherapy
- Trial name
- NCT04070313
- Testing
- S-1
- Where
- 4 sites in Taiwan
- Volunteers
- 36 people
- Sponsor
- TTY Biopharm